Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2019 | 154 | 0.91 | Why? |
| Virus Latency | 2 | 2018 | 251 | 0.73 | Why? |
| Somatic Hypermutation, Immunoglobulin | 1 | 2018 | 283 | 0.69 | Why? |
| Alternative Splicing | 1 | 2017 | 82 | 0.68 | Why? |
| Anti-HIV Agents | 3 | 2018 | 2209 | 0.63 | Why? |
| Transcription Factors | 2 | 2018 | 784 | 0.58 | Why? |
| Models, Genetic | 1 | 2017 | 434 | 0.58 | Why? |
| HIV | 2 | 2017 | 1116 | 0.50 | Why? |
| HIV Infections | 10 | 2019 | 11620 | 0.50 | Why? |
| Interferon-alpha | 1 | 2019 | 1442 | 0.42 | Why? |
| Anti-Retroviral Agents | 2 | 2018 | 1099 | 0.42 | Why? |
| RNA | 1 | 2017 | 1278 | 0.40 | Why? |
| Virus Replication | 3 | 2019 | 14331 | 0.35 | Why? |
| Receptors, Antigen, T-Cell | 3 | 2018 | 760 | 0.35 | Why? |
| Graft Enhancement, Immunologic | 1 | 2006 | 1 | 0.33 | Why? |
| T-Lymphocytes | 4 | 2019 | 6670 | 0.33 | Why? |
| Simian Immunodeficiency Virus | 3 | 2019 | 251 | 0.33 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.32 | Why? |
| CD8-Positive T-Lymphocytes | 6 | 2018 | 5837 | 0.30 | Why? |
| Signal Transduction | 2 | 2019 | 7207 | 0.29 | Why? |
| Interferon Type I | 1 | 2018 | 2789 | 0.29 | Why? |
| Gene Expression Regulation | 1 | 2017 | 4020 | 0.28 | Why? |
| Hematopoietic Stem Cells | 1 | 2006 | 321 | 0.25 | Why? |
| CD4-Positive T-Lymphocytes | 5 | 2018 | 4545 | 0.25 | Why? |
| Antibodies, Neutralizing | 10 | 2021 | 25288 | 0.24 | Why? |
| Graft vs Host Disease | 1 | 2006 | 501 | 0.23 | Why? |
| Primates | 2 | 2021 | 584 | 0.23 | Why? |
| HIV Antibodies | 2 | 2018 | 776 | 0.22 | Why? |
| Single Molecule Imaging | 1 | 2021 | 126 | 0.21 | Why? |
| Lymphoid Tissue | 2 | 2018 | 162 | 0.21 | Why? |
| Immunity, Innate | 1 | 2019 | 6570 | 0.21 | Why? |
| Vaccines | 2 | 2020 | 3692 | 0.20 | Why? |
| Lymphocyte Activation | 3 | 2018 | 2742 | 0.20 | Why? |
| Models, Statistical | 1 | 2017 | 5312 | 0.20 | Why? |
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2018 | 28 | 0.19 | Why? |
| Inflammation | 2 | 2019 | 13255 | 0.19 | Why? |
| Receptors, Interferon | 1 | 2018 | 64 | 0.19 | Why? |
| Nucleotide Motifs | 1 | 2018 | 58 | 0.18 | Why? |
| RNA Splice Sites | 1 | 2017 | 40 | 0.18 | Why? |
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 130 | 0.18 | Why? |
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2019 | 203 | 0.17 | Why? |
| Interleukin-15 | 1 | 2018 | 169 | 0.17 | Why? |
| Mitochondrial Proteins | 1 | 2018 | 152 | 0.17 | Why? |
| Vaccine Potency | 1 | 2018 | 339 | 0.16 | Why? |
| Complementarity Determining Regions | 1 | 2017 | 147 | 0.16 | Why? |
| Administrative Personnel | 1 | 2020 | 326 | 0.16 | Why? |
| Granzymes | 1 | 2017 | 197 | 0.16 | Why? |
| Receptors, CCR5 | 1 | 2018 | 186 | 0.16 | Why? |
| Immunogenicity, Vaccine | 3 | 2021 | 4624 | 0.16 | Why? |
| Chemoradiotherapy | 1 | 2018 | 362 | 0.15 | Why? |
| Software | 2 | 2018 | 2501 | 0.15 | Why? |
| Antigens | 1 | 2018 | 267 | 0.15 | Why? |
| Stochastic Processes | 1 | 2017 | 369 | 0.15 | Why? |
| Molecular Sequence Annotation | 1 | 2018 | 478 | 0.15 | Why? |
| DNA-Binding Proteins | 1 | 2018 | 469 | 0.15 | Why? |
| Cross Reactions | 3 | 2021 | 4374 | 0.15 | Why? |
| Common Cold | 1 | 2021 | 645 | 0.14 | Why? |
| HIV-1 | 4 | 2018 | 3365 | 0.14 | Why? |
| Antibodies, Bispecific | 1 | 2017 | 207 | 0.14 | Why? |
| Macaca mulatta | 3 | 2021 | 3716 | 0.14 | Why? |
| Immunotherapy, Adoptive | 1 | 2019 | 524 | 0.14 | Why? |
| Base Sequence | 2 | 2021 | 3581 | 0.13 | Why? |
| Cytomegalovirus | 1 | 2019 | 600 | 0.13 | Why? |
| Databases, Protein | 1 | 2018 | 523 | 0.13 | Why? |
| Virus Activation | 1 | 2018 | 480 | 0.13 | Why? |
| AIDS Vaccines | 1 | 2018 | 452 | 0.13 | Why? |
| Amino Acid Sequence | 4 | 2018 | 6049 | 0.13 | Why? |
| B-Lymphocytes | 2 | 2018 | 4418 | 0.13 | Why? |
| Cytomegalovirus Infections | 1 | 2019 | 667 | 0.12 | Why? |
| Animals | 11 | 2021 | 78931 | 0.12 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2018 | 698 | 0.12 | Why? |
| Immunity, Herd | 1 | 2020 | 1011 | 0.12 | Why? |
| CD4 Lymphocyte Count | 3 | 2018 | 1517 | 0.11 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.11 | Why? |
| Brain Neoplasms | 1 | 2018 | 669 | 0.11 | Why? |
| Antibodies, Viral | 10 | 2021 | 51949 | 0.11 | Why? |
| Interleukin-7 Receptor alpha Subunit | 1 | 2008 | 13 | 0.09 | Why? |
| Drug Delivery Systems | 1 | 2019 | 1365 | 0.09 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.09 | Why? |
| Evolution, Molecular | 2 | 2021 | 3691 | 0.09 | Why? |
| Sequence Analysis, RNA | 1 | 2017 | 2290 | 0.09 | Why? |
| Disaster Planning | 1 | 2020 | 1680 | 0.08 | Why? |
| Genes, T-Cell Receptor beta | 1 | 2006 | 22 | 0.08 | Why? |
| Melanoma | 1 | 2018 | 1229 | 0.08 | Why? |
| Leukocyte Reduction Procedures | 1 | 2006 | 19 | 0.08 | Why? |
| Interleukin-2 Receptor alpha Subunit | 1 | 2008 | 234 | 0.08 | Why? |
| WT1 Proteins | 1 | 2005 | 15 | 0.08 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.08 | Why? |
| Cells, Cultured | 1 | 2017 | 5835 | 0.08 | Why? |
| Transplantation | 1 | 2006 | 72 | 0.08 | Why? |
| Mesocricetus | 2 | 2021 | 1847 | 0.08 | Why? |
| Coculture Techniques | 1 | 2006 | 258 | 0.07 | Why? |
| Communicable Diseases, Emerging | 1 | 2020 | 2523 | 0.07 | Why? |
| Antigens, Surface | 1 | 2006 | 181 | 0.07 | Why? |
| Cell Proliferation | 2 | 2018 | 1973 | 0.07 | Why? |
| Th2 Cells | 1 | 2008 | 680 | 0.07 | Why? |
| Viral Load | 4 | 2021 | 15850 | 0.07 | Why? |
| Humans | 29 | 2021 | 930598 | 0.07 | Why? |
| HLA-A Antigens | 1 | 2005 | 196 | 0.07 | Why? |
| Antigens, Viral | 1 | 2021 | 6298 | 0.07 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| Cricetinae | 2 | 2021 | 3344 | 0.06 | Why? |
| Transplantation, Homologous | 1 | 2006 | 757 | 0.06 | Why? |
| Population Surveillance | 1 | 2020 | 4967 | 0.06 | Why? |
| Viral Proteins | 1 | 2021 | 7370 | 0.06 | Why? |
| Computer Simulation | 1 | 2017 | 4982 | 0.06 | Why? |
| Mice | 2 | 2019 | 21357 | 0.06 | Why? |
| Vaccination | 4 | 2021 | 19050 | 0.06 | Why? |
| Viral Vaccines | 2 | 2021 | 7560 | 0.05 | Why? |
| Immunodominant Epitopes | 1 | 2005 | 813 | 0.05 | Why? |
| Immune Evasion | 2 | 2021 | 2081 | 0.05 | Why? |
| Leukemia | 1 | 2005 | 598 | 0.05 | Why? |
| Models, Immunological | 1 | 2006 | 727 | 0.05 | Why? |
| T-Lymphocyte Subsets | 1 | 2008 | 1387 | 0.05 | Why? |
| Antigen-Antibody Reactions | 1 | 2021 | 616 | 0.05 | Why? |
| Macaca | 1 | 2021 | 388 | 0.05 | Why? |
| British Columbia | 1 | 2021 | 512 | 0.05 | Why? |
| Clonal Anergy | 1 | 2018 | 11 | 0.05 | Why? |
| Polyproteins | 1 | 2021 | 814 | 0.04 | Why? |
| HIV Seronegativity | 1 | 2018 | 112 | 0.04 | Why? |
| Major Histocompatibility Complex | 1 | 2018 | 70 | 0.04 | Why? |
| Immunoglobulin Fab Fragments | 1 | 2021 | 556 | 0.04 | Why? |
| Protein Domains | 2 | 2021 | 6563 | 0.04 | Why? |
| Clone Cells | 1 | 2018 | 312 | 0.04 | Why? |
| Single-Cell Analysis | 2 | 2018 | 2450 | 0.04 | Why? |
| Models, Animal | 1 | 2020 | 788 | 0.04 | Why? |
| Antiviral Agents | 2 | 2021 | 41703 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| Collagen | 1 | 2018 | 222 | 0.04 | Why? |
| Administration, Intranasal | 1 | 2021 | 1132 | 0.04 | Why? |
| Lymph Nodes | 2 | 2017 | 1060 | 0.04 | Why? |
| Tissue Donors | 1 | 2006 | 1679 | 0.04 | Why? |
| Perforin | 1 | 2017 | 136 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Immunologic Memory | 1 | 2008 | 3362 | 0.04 | Why? |
| Yellow Fever Vaccine | 1 | 2018 | 198 | 0.04 | Why? |
| Antibody Affinity | 1 | 2021 | 1078 | 0.04 | Why? |
| Trachea | 1 | 2021 | 894 | 0.04 | Why? |
| Palatine Tonsil | 1 | 2017 | 127 | 0.04 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2018 | 3633 | 0.04 | Why? |
| Yellow fever virus | 1 | 2017 | 205 | 0.04 | Why? |
| Models, Molecular | 2 | 2021 | 7616 | 0.04 | Why? |
| Healthy Volunteers | 1 | 2021 | 1444 | 0.04 | Why? |
| Sequence Homology, Amino Acid | 1 | 2018 | 945 | 0.04 | Why? |
| Geography | 1 | 2021 | 1801 | 0.04 | Why? |
| Peptide Library | 1 | 2018 | 564 | 0.03 | Why? |
| Fibrosis | 1 | 2018 | 800 | 0.03 | Why? |
| Uganda | 1 | 2018 | 1057 | 0.03 | Why? |
| Weather | 1 | 2020 | 581 | 0.03 | Why? |
| Mutation | 3 | 2021 | 12376 | 0.03 | Why? |
| Protein Structure, Secondary | 1 | 2018 | 1077 | 0.03 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.03 | Why? |
| Immunization, Secondary | 1 | 2021 | 1649 | 0.03 | Why? |
| DNA, Viral | 2 | 2017 | 2521 | 0.03 | Why? |
| Immune Tolerance | 1 | 2018 | 608 | 0.03 | Why? |
| Protein Binding | 2 | 2021 | 11430 | 0.03 | Why? |
| Interdisciplinary Communication | 1 | 2020 | 1425 | 0.03 | Why? |
| Climate Change | 1 | 2020 | 901 | 0.03 | Why? |
| Male | 11 | 2021 | 367725 | 0.03 | Why? |
| Female | 11 | 2021 | 380317 | 0.03 | Why? |
| Adjuvants, Immunologic | 1 | 2021 | 1709 | 0.03 | Why? |
| Sequence Alignment | 1 | 2018 | 2109 | 0.03 | Why? |
| Cell Differentiation | 1 | 2017 | 1338 | 0.03 | Why? |
| Communicable Disease Control | 1 | 2020 | 29620 | 0.03 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2018 | 2134 | 0.03 | Why? |
| Mass Vaccination | 1 | 2020 | 1101 | 0.02 | Why? |
| Lysosomal-Associated Membrane Protein 1 | 1 | 2008 | 27 | 0.02 | Why? |
| Cercocebus atys | 1 | 2008 | 5 | 0.02 | Why? |
| Tumor Necrosis Factor Receptor Superfamily, Member 7 | 1 | 2008 | 58 | 0.02 | Why? |
| Drug Design | 1 | 2021 | 2627 | 0.02 | Why? |
| Nanoparticles | 1 | 2021 | 2040 | 0.02 | Why? |
| Leukocyte Common Antigens | 1 | 2008 | 101 | 0.02 | Why? |
| Cytokines | 3 | 2018 | 15010 | 0.02 | Why? |
| Thymus Gland | 1 | 2009 | 126 | 0.02 | Why? |
| Middle Aged | 8 | 2021 | 270681 | 0.02 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.02 | Why? |
| Anti-Infective Agents | 1 | 2020 | 1766 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| In Situ Hybridization | 1 | 2009 | 390 | 0.02 | Why? |
| Neutralization Tests | 1 | 2021 | 6698 | 0.02 | Why? |
| Adult | 7 | 2021 | 244371 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.02 | Why? |
| Zoonoses | 1 | 2020 | 3034 | 0.02 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.02 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2021 | 7868 | 0.02 | Why? |
| Cell Line | 1 | 2021 | 12040 | 0.02 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.02 | Why? |
| Forecasting | 1 | 2020 | 4492 | 0.02 | Why? |
| Hematopoietic Stem Cell Transplantation | 1 | 2019 | 2426 | 0.02 | Why? |
| HLA-A2 Antigen | 1 | 2005 | 134 | 0.02 | Why? |
| Immunoassay | 1 | 2021 | 4485 | 0.02 | Why? |
| Binding Sites | 1 | 2018 | 6201 | 0.02 | Why? |
| Immunization, Passive | 1 | 2021 | 10067 | 0.02 | Why? |
| SARS Virus | 1 | 2008 | 13021 | 0.02 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2008 | 12361 | 0.02 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.02 | Why? |
| Vero Cells | 1 | 2021 | 14117 | 0.02 | Why? |
| Receptors, Virus | 1 | 2021 | 5659 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Disease Models, Animal | 1 | 2021 | 10998 | 0.02 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Lymphocyte Subsets | 1 | 2009 | 987 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| Cohort Studies | 2 | 2020 | 36005 | 0.01 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.01 | Why? |
| Coronavirus Infections | 2 | 2020 | 253789 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.01 | Why? |
| Mass Screening | 1 | 2020 | 8005 | 0.01 | Why? |
| Molecular Sequence Data | 1 | 2005 | 3198 | 0.01 | Why? |
| Betacoronavirus | 2 | 2021 | 204454 | 0.01 | Why? |
| Internet | 1 | 2018 | 6204 | 0.01 | Why? |
| Young Adult | 2 | 2021 | 93724 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2018 | 8041 | 0.01 | Why? |
| Proteome | 1 | 2008 | 1812 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Immunoglobulin G | 1 | 2021 | 21571 | 0.01 | Why? |
| Cell Line, Tumor | 1 | 2005 | 3608 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Peptides | 1 | 2005 | 2513 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2021 | 53120 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Aged | 2 | 2021 | 215776 | 0.01 | Why? |
| Lung | 1 | 2021 | 31049 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Disease Progression | 1 | 2008 | 13580 | 0.01 | Why? |